StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 177.00
-3.00 (-1.67%)
Sep 16, 2026, 3:08 PM JST
StemRIM Market Cap
StemRIM has a market cap or net worth of 11.28 billion as of September 15, 2026. Its market cap has decreased by -40.47% in one year.
Market Cap
11.28B
Enterprise Value
5.91B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
177.00
ChartMarket Cap Chart
Since August 9, 2019, StemRIM's market cap has decreased from 49.82B to 11.28B, a decrease of -77.35%. That is a compound annual growth rate of -18.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 11.28B | -31.56% |
| Dec 30, 2025 | 16.49B | -15.37% |
| Dec 30, 2024 | 19.48B | -45.16% |
| Dec 29, 2023 | 35.52B | -34.08% |
| Dec 30, 2022 | 53.89B | 3.59% |
| Dec 30, 2021 | 52.02B | 40.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnGes | 14.36B |
| CanBas | 14.12B |
| RaQualia Pharma | 14.11B |
| ReproCELL | 14.02B |
| Immuno-Biological Laboratories | 10.79B |
| Kubota Pharmaceutical Holdings | 10.70B |
| K Pharma,Inc. | 9.55B |
| Carna Biosciences | 9.05B |